Aurinia Pharmaceuticals

AUPH

Market cap $2.01B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$17.33

14% upside

High target

positive

2 neutral

67%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Leerink Partners Joseph Schwartz				3 Dec ‘25 1 month ago
Jefferies Maury Raycroft 100% 1-yr AUPH win rate				7 Nov ‘25 2 months ago
RBC Capital Douglas Miehm 100% 1-yr AUPH win rate				5 Nov ‘25 2 months ago